BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings

Reuters

Feb 12

BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings

** Shares of CSL Ltd CSL.AX fall 7.8% to A$150.660, extending losses into their sixth consecutive session

** Stock is down 15% for the week, with most of the losses coming since Wednesday, after CEO Paul McKenzie announced retirement

** If the trend holds, CSL would post its worst week since late October

** CSL on Wednesday also reported an 81% drop in its first-half profit, hurt by weaker plasma and vaccine sales and one-off charges

** CSL stock, once the priciest in Australia, is down 43% since August, when it first announced the spinoff of its influenza vaccine division, Seqirus, and flagged a broader restructuring

** CSL stock's relative strength index $(RSI)$ dipped below 30 on Wednesday for the first time since early November — a threshold market participants consider indicative of being oversold

** CSL stock down 11.6% this year, including the day's move

(Reporting by Sameer Manekar in Bengaluru)

((Sameer.Manekar@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2610995250"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610995250\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610995250?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 09:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610995250","market":"fut","top_or_hot":-1,"title":"BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings</title></head><body><p>** Shares of CSL Ltd <span>CSL.AX</span> fall 7.8% to A$150.660, extending losses into their sixth consecutive session</p><p>** Stock is down 15% for the week, with most of the losses coming since Wednesday, after <span>CEO Paul McKenzie announced retirement</span></p><p>** If the trend holds, CSL would post its worst week since late October</p><p>** CSL on Wednesday also <span>reported</span> an 81% drop in its first-half profit, hurt by weaker plasma and vaccine sales and one-off charges</p><p>** CSL stock, once the priciest in Australia, is down 43% since August, when it first announced the spinoff of its influenza vaccine division, Seqirus, and flagged a broader restructuring</p><p>** CSL stock's relative strength index <a href=\"https://laohu8.com/S/RSI\">$(RSI)$</a> dipped below 30 on Wednesday for the first time since early November — a threshold market participants consider indicative of being oversold</p><p>** CSL stock down 11.6% this year, including the day's move</p><p>(Reporting by Sameer Manekar in Bengaluru)</p><p>((Sameer.Manekar@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-CSL rout extends into sixth session after CEO departure, weak earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-12 09:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings</title></head><body><p>** Shares of CSL Ltd <span>CSL.AX</span> fall 7.8% to A$150.660, extending losses into their sixth consecutive session</p><p>** Stock is down 15% for the week, with most of the losses coming since Wednesday, after <span>CEO Paul McKenzie announced retirement</span></p><p>** If the trend holds, CSL would post its worst week since late October</p><p>** CSL on Wednesday also <span>reported</span> an 81% drop in its first-half profit, hurt by weaker plasma and vaccine sales and one-off charges</p><p>** CSL stock, once the priciest in Australia, is down 43% since August, when it first announced the spinoff of its influenza vaccine division, Seqirus, and flagged a broader restructuring</p><p>** CSL stock's relative strength index <a href=\"https://laohu8.com/S/RSI\">$(RSI)$</a> dipped below 30 on Wednesday for the first time since early November — a threshold market participants consider indicative of being oversold</p><p>** CSL stock down 11.6% this year, including the day's move</p><p>(Reporting by Sameer Manekar in Bengaluru)</p><p>((Sameer.Manekar@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7067","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nL4N3Z8048:1","article_id":"2610995250","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610995250","pubTimestamp":1770859599,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings** Shares of CSL Ltd CSL.AX fall 7.8% to A$150.660, extending losses into their sixth consecutive session** Stock is down 15% for the week, with most of the losses coming since Wednesday, after CEO Paul McKenzie announced retirement** If the trend holds, CSL would post its worst week since late October** CSL on Wednesday also reported an 81% drop in its first-half profit, hurt by weaker plasma and vaccine sales and one-off charges** CSL stock, once the priciest in Australia, is down 43% since August, when it first announced the spinoff of its influenza vaccine division, Seqirus, and flagged a broader restructuring** CSL stock's relative strength index  dipped below 30 on Wednesday for the first time since early November — a threshold market participants consider indicative of being oversold** CSL stock down 11.6% this year, including the day's move","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7067":"生物科技","CSL.AU":"CSL LIMITED","BK7511":"ESG概念","BK7508":"医药生物股","BK7501":"新冠治疗股"},"translate_title":"首席执行官离职、盈利疲软后，CSL溃败延续至第六个交易日","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL.AU":0.9},"content_text":"BUZZ-CSL rout extends into sixth session after CEO departure, weak earnings** Shares of CSL Ltd CSL.AX fall 7.8% to A$150.660, extending losses into their sixth consecutive session** Stock is down 15% for the week, with most of the losses coming since Wednesday, after CEO Paul McKenzie announced retirement** If the trend holds, CSL would post its worst week since late October** CSL on Wednesday also reported an 81% drop in its first-half profit, hurt by weaker plasma and vaccine sales and one-off charges** CSL stock, once the priciest in Australia, is down 43% since August, when it first announced the spinoff of its influenza vaccine division, Seqirus, and flagged a broader restructuring** CSL stock's relative strength index $(RSI)$ dipped below 30 on Wednesday for the first time since early November — a threshold market participants consider indicative of being oversold** CSL stock down 11.6% this year, including the day's move(Reporting by Sameer Manekar in Bengaluru)((Sameer.Manekar@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"executive,dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}